NVIDIA Corporation

GE HealthCare has announced the submission of its next-generation SIGNA MRI technology for FDA clearance, including SIGNA Bolt 3T MRI and SIGNA Sprint with Freelium 1.5T MRI systems. These new systems are designed to enhance precision diagnostics, improve efficiency with AI-powered workflows via SIGNA One, and advance sustainability through reduced helium usage. The company aims to address challenges in healthcare such as long wait times and clinician burnout by providing smarter, more accessible, and impactful MRI solutions.

Veteran analyst Ed Yardeni predicts an early Santa Claus rally for U.S. equities, citing recent market recovery and positive sentiment. The market's upward trend aligns with earlier predictions, with the Dow, S&P 500, and Nasdaq seeing significant gains during Thanksgiving week. Optimism is further fueled by Alphabet's new Gemini 3 language model and hints of a possible Fed interest rate cut, despite AI bellwether Nvidia's recent dip.

Broadcom (AVGO) is heading into December 2025 trading near record highs, driven by significant AI-driven enthusiasm, including custom AI accelerator deals with OpenAI and Google. The stock saw an 18% rally in the past week, fueled by bullish analyst predictions, options market activity, and institutional trading updates. With a market capitalization nearing $1.9 trillion, the market is closely watching how AVGO will perform at the December 1, 2025, open and leading up to its Q4 and full-year earnings report on December 11.

Intel's stock experienced a volatile rally driven by rumors of Apple potentially tapping Intel as a foundry supplier for its M-series processors, which led to a significant surge. This speculative upside is balanced by a deepening legal dispute with TSMC over alleged trade-secret theft involving a former executive. The stock's performance is also bolstered by broader AI GPU market tailwinds, improved Q3 2025 financials, significant government backing, and strategic partnerships, despite cautious analyst sentiment.